Revolutionizing Antibody Drug Discovery with AI-Driven Innovation

Our proprietary AI-driven platform is at the heart of everything we do. By combining state-of-the-art computational biology with advanced machine learning models, we are able to streamline the entire antibody discovery process. First, we use AI to predict the protein structure and identify key binding pockets. Once these targets are identified, our algorithms generate antibody candidates that are precisely designed to bind to the target residues. From there, we optimize the antibodies by assessing critical factors such as thermostability, immunogenicity, hydrophobicity, electrostatic properties, and human compatibility. Each candidate is rigorously tested through computational simulations and high-throughput assays to ensure its stability and effectiveness. The result is a platform that accelerates antibody discovery, improves the performance of each antibody, and ensures that every therapeutic candidate is ready for clinical advancement with minimal risk of failure.

Smart Antibody Design

Target Discovery and Antibody Design

Antibody drugs are among the most promising treatments for cancer, autoimmune disorders, and infectious diseases. By leveraging AI, we’re not only accelerating their discovery but also unlocking new possibilities to treat diseases once considered untreatable.

The development of antibody-based therapeutics represents one of the most promising avenues in modern medicine, offering highly specific and effective treatments for a range of diseases. At Eavono, we leverage cutting-edge artificial intelligence and computational biology to transform the traditional antibody drug discovery process, accelerating timelines and enhancing precision.

We deploy our proprietary antibody-generation algorithms to design diverse antibody candidates. These algorithms explore a vast design space, generating heavy and light chains tailored to bind specifically and robustly to the identified target residues. By simulating interactions at an atomic level, we ensure high affinity and specificity for the target protein.